GlassScriptPhysician profile
Anthony F Izzo
NPI 1215198692
$46,751.07
in general payments reported to CMS, 2019-2025
46 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $862 · 2021: $2,121 · 2022: $1,138 · 2023: $1,204 · 2024: $15K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $4,987 · Consulting Fee: $4,697 · Travel and Lodging: $2,034 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,960.00 |
| Food and Beverage | $4,987.08 |
| Consulting Fee | $4,696.50 |
| Travel and Lodging | $2,034.18 |
| Education | $218.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $40,938.30 | 2019-2025 | |
| Abbvie INC. | $897.88 | 2021-2025 | |
| Biogen, INC. | $512.72 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Teva Pharmaceuticals USA, INC. | $479.44 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lundbeck LLC | $462.55 | 2023-2025 | Vyepti |
| Harmony Biosciences LLC | $416.77 | 2021-2025 | Wakix |
| Inspire Medical Systems, INC. | $366.18 | 2023-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $223.21 | 2022-2025 | |
| Sk Life Science, INC. | $181.84 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $167.13 | 2023-2024 | Nuplazid |
| Pfizer INC. | $129.20 | 2022-2025 | |
| Celgene Corporation | $124.47 | 2022-2025 | Zeposia |
| Genzyme Corporation | $117.06 | 2021-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $114.93 | 2024-2025 | Lumryz |
| Sunovion Pharmaceuticals INC. | $113.10 | 2021-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $111.33 | 2025 | |
| Tg Therapeutics, INC. | $110.30 | 2024-2025 | |
| Ucb, INC. | $106.97 | 2022-2023 | Briviact, Fintepla |
| Lilly USA, LLC | $100.94 | 2024-2025 | Zepbound, Kisunla, Emgality |
| Argenx US, INC. | $94.15 | 2024-2025 | Vyvgart Hytrulo |
| Biohaven Pharmaceuticals, INC. | $92.05 | 2021 | |
| Eisai INC. | $80.36 | 2021-2024 | |
| Axsome Therapeutics, INC. | $77.22 | 2022-2025 | Sunosi |
| Csl Behring | $64.45 | 2022-2024 | Hizentra |
| Amgen INC. | $60.18 | 2021-2023 | Aimovig |
| Genentech USA, INC. | $54.14 | 2021-2023 | Enspryng, Ocrevus |
| Amneal Pharmaceuticals LLC | $53.73 | 2024 | Ongentys, Ongentys 50mg Capsules 30 |
| Astrazeneca Pharmaceuticals LP | $48.29 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $42.93 | 2022-2023 | Ingrezza, Ongentys |
| Mallinckrodt Hospital Products INC. | $42.13 | 2022-2023 | Acthar |
| Emd Serono, INC. | $41.75 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $36.81 | 2022 | |
| Allergan, INC. | $27.50 | 2021 | |
| Grifols USA, LLC | $24.87 | 2024 | Gamunex-C |
| Amylyx Pharmaceuticals, INC. | $24.70 | 2023 | Relyvrio |
| Medtronic, INC. | $22.82 | 2023 | Synchromedii |
| Alexion Pharmaceuticals, INC. | $22.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.81 | 2023 | |
| Mdd US Operations, LLC | $20.65 | 2022 | |
| Acorda Therapeutics, INC | $20.25 | 2021 | |
| Impel Pharmaceuticals INC. | $19.45 | 2023 | Trudhesa |
| Avion Pharmaceuticals | $18.97 | 2023 | Dhivy |
| E.R. Squibb & Sons, L.L.C. | $17.95 | 2022 | |
| Livanova USA, INC. | $17.69 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Kyowa Kirin, INC. | $15.88 | 2023 | Nourianz |
| Zoll Respicardia, INC. | $14.57 | 2024 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Izzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.